Compare AMRX & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | MEOH |
|---|---|---|
| Founded | 2002 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 2018 | 1995 |
| Metric | AMRX | MEOH |
|---|---|---|
| Price | $12.81 | $64.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $15.60 | ★ $58.33 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.48 | $25.43 |
| Revenue Next Year | $7.13 | N/A |
| P/E Ratio | $58.41 | ★ $16.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.02 | $31.57 |
| 52 Week High | $15.42 | $66.75 |
| Indicator | AMRX | MEOH |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 59.92 |
| Support Level | $12.45 | $46.36 |
| Resistance Level | $12.85 | $66.75 |
| Average True Range (ATR) | 0.48 | 2.21 |
| MACD | -0.00 | 0.48 |
| Stochastic Oscillator | 29.84 | 88.01 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.